secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2021-10-22T23:59:59+00:00
Accession:  0001607062-21-000444
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen BioPharma settles convertible notes for $43,529 cash to avoid potential issuance of 855M shares
--------------------------------------------------------------------------------

- Settled convertible notes principal of $29,836 and accrued interest of $26,227 for $43,529.30 cash.
- Notes had a default conversion provision allowing conversion at 65% of lowest bid price during delinquency.
- Company determined provision could permit conversion even after cure, enabling up to 855,584,615 shares worth $16.6M.
- Settlement eliminates the default-conversion risk and potential massive dilution for existing shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000444/0001607062-21-000444-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000444/rgbp102221form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-21-000444

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer